Cargando…

Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD

BACKGROUND: Alpha-1-antitrypsin deficiency (AATD) is an under-diagnosed condition in patients with chronic obstructive pulmonary disease (COPD). The aim of this study was to screen for AATD in Kazakh patients with COPD using dried blood spot specimens. METHODS: The alpha1-antitrypsin (AAT) concentra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhumagaliyeva, Ardak, Ottaviani, Stefania, Greulich, Timm, Gorrini, Marina, Vogelmeier, Claus, Karazhanova, Ludmila, Nurgazina, Gulmira, DeSilvestri, Annalisa, Kotke, Victor, Barzon, Valentina, Zorzetto, Michele, Corsico, Angelo, Ferrarotti, Ilaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655868/ https://www.ncbi.nlm.nih.gov/pubmed/29090095 http://dx.doi.org/10.1186/s40248-017-0104-5

Ejemplares similares

Update on α(1)-antitrypsin deficiency
por: Ferrarotti, Ilaria, et al.
Publicado: (2018)

Molecular diagnosis of alpha1‐antitrypsin deficiency: A new method based on Luminex technology
por: Ottaviani, Stefania, et al.
Publicado: (2020)

COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale
por: Ferrarotti, I., et al.
Publicado: (2021)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
por: Veith, Martina, et al.
Publicado: (2020)

Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015
por: Greulich, Timm, et al.
Publicado: (2016)

Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency
por: Barzon, Valentina, et al.
Publicado: (2022)

Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology
por: Veith, Martina, et al.
Publicado: (2019)

Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report
por: Denden, Sabri, et al.
Publicado: (2009)

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
por: Chorostowska-Wynimko, Joanna, et al.
Publicado: (2020)

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
por: Karl, Florian M., et al.
Publicado: (2017)

Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration
por: Bari, Elia, et al.
Publicado: (2019)

How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?
por: Ferrarotti, Ilaria, et al.
Publicado: (2015)

Safety of biweekly α(1)-antitrypsin treatment in the RAPID programme
por: Greulich, Timm, et al.
Publicado: (2018)

Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency
por: Greulich, Timm, et al.
Publicado: (2018)

Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD
por: Balbi, Bruno, et al.
Publicado: (2019)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
por: Fähndrich, Sebastian, et al.
Publicado: (2017)

Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency
por: Koczulla, A-Rembert, et al.
Publicado: (2012)

Therapy with Plasma Purified Alpha1-Antitrypsin (Prolastin(®)) Induces Time-Dependent Changes in Plasma Levels of MMP-9 and MPO
por: Koepke, Janine, et al.
Publicado: (2015)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
por: Janciauskiene, Sabina, et al.
Publicado: (2018)

The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency
por: Pini, Laura, et al.
Publicado: (2014)

Research priorities in α(1)-antitrypsin deficiency: results of a patients' and healthcare providers' international survey from the EARCO Clinical Research Collaboration
por: Barrecheguren, Miriam, et al.
Publicado: (2020)

Y-Chromosome Variation in Altaian Kazakhs Reveals a Common Paternal Gene Pool for Kazakhs and the Influence of Mongolian Expansions
por: Dulik, Matthew C., et al.
Publicado: (2011)

Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α(1)-Antitrypsin Deficiency
por: Rigobello, Chiara, et al.
Publicado: (2019)

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
por: Herth, Felix J F, et al.
Publicado: (2021)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

The Importance of N186 in the Alpha-1-Antitrypsin Shutter Region Is Revealed by the Novel Bologna Deficiency Variant
por: Ronzoni, Riccardo, et al.
Publicado: (2021)

High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients – a retrospective analysis
por: Greulich, Timm, et al.
Publicado: (2020)

Association of polymorphisms in TP53 and the promoter region of IL10 with gastric cancer in a Kazakh population
por: Kulmambetova, Gulmira, et al.
Publicado: (2020)

The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency
por: Schmid, ST, et al.
Publicado: (2012)

The pathological Trento variant of alpha‐1‐antitrypsin (E75V) shows nonclassical behaviour during polymerization
por: Miranda, Elena, et al.
Publicado: (2017)

Long-term effect of α(1)-antitrypsin augmentation therapy on the decline of FEV(1) in deficient patients: an analysis of the AIR database
por: Schouten, Iris G.M., et al.
Publicado: (2021)

Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews
por: Miravitlles, Marc, et al.
Publicado: (2022)

Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population
por: Zholdybayeva, Elena V., et al.
Publicado: (2016)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

Protocol for the EARCO Registry: a pan-European observational study in patients with α(1)-antitrypsin deficiency
por: Greulich, Timm, et al.
Publicado: (2020)

Clinical manifestations of a new alpha‐1 antitrypsin genetic variant: Q0parma
por: Aiello, Marina, et al.
Publicado: (2022)

Association Between the P2RY12 Receptor Gene Polymorphism and Aspirin Resistance in Patients with Coronary Artery Disease
por: Karazhanova, Ludmila, et al.
Publicado: (2014)

Validity and Usability of Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Boeselt, Tobias, et al.
Publicado: (2016)

Treatment response in COPD: does FEV(1) say it all? A post hoc analysis of the CRYSTAL study
por: Kostikas, Konstantinos, et al.
Publicado: (2019)

COPD in individuals with the PiMZ alpha-1 antitrypsin genotype
por: Al Ashry, Haitham S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k5ma265ta54p2jlqq2s624jfe2